Retina and Ocular Diabetes
OCT for Diabetic Macular Edema: How It Helps Monitor Treatment
Read this guide
High Vision
Schedule an appointment
Choose how to contact the office.
Retina and Ocular Diabetes
Choose how to contact the office.
In brief: Optical coherence tomography (OCT) is the reference test for detecting, measuring, and monitoring diabetic macular edema (DME) during treatment. It allows the specialist to compare retinal thickness at each visit and decide whether to adjust, continue, or space out interventions. OCT images are not designed for patients to interpret on their own; their value lies in the comparative review the doctor performs over time.
Diabetic macular edema is the buildup of fluid in the macula—the central area of the retina responsible for fine vision—as a result of diabetes. When this fluid alters the retinal architecture, central vision becomes distorted or less sharp. It is the eye complication that most often causes moderate vision loss in people with diabetes.
DME is characterized by fluid buildup in the macula, which can lead to significant vision loss and even blindness if not treated in time. (Proportion, patterns and Factors Associated with Diabetic Macular Edema among Diabetes Type 2 Patients attending KCMC Hospital 2023-2024) Diabetes currently affects about 537 million adults worldwide; approximately one-third develop diabetic retinopathy, and between 5 and 11 % of people with type 2 diabetes go on to develop DME. (Proportion, patterns and Factors Associated with Diabetic Macular Edema among Diabetes Type 2 Patients attending KCMC Hospital 2023-2024)
In Mexico, diabetic retinopathy is present in approximately 1 out of every 3 people with diabetes in the country. ((PDF) Approach to macular edema caused by diabetic retinopathy in Mexican adults) Among the microvascular complications of diabetes, diabetic macular edema is the leading cause of preventable vision loss in adults. (Revista Cubana de Medicina Militar (Dec 2025))
The underlying cause is chronic hyperglycemia, which damages the retinal capillaries and disrupts the blood-retinal barrier. Factors such as high blood pressure, dyslipidemia, and duration of diabetes increase the risk. Poorly controlled high blood pressure, older age, and a longer duration of diabetes are closely linked to the presence of DME. (Revista Cubana de Medicina Militar (Dec 2025))
DME may have no symptoms in its early stages, or it may present as blurred central vision, distorted straight lines, or muted colors. Distinguishing it from other causes of blurred vision—such as cataracts or presbyopia—requires a clinical assessment with OCT, not just a description of the symptom.
Characteristic: Affected area
Diabetic macular edema: Primarily central vision
Cataracts: Diffuse, generalized vision
Dry eye: Variable vision that worsens at the end of the day
Characteristic: Line distortion
Diabetic macular edema: Yes, common (metamorphopsia)
Cataracts: Rare
Dry eye: Rare
Characteristic: Color changes
Diabetic macular edema: Possible (muted colors)
Cataracts: Progressive yellowing
Dry eye: Not typical
Characteristic: Day-to-day fluctuation
Diabetic macular edema: May fluctuate with blood glucose levels
Cataracts: Stable
Dry eye: Worsens with prolonged screen use
Characteristic: Association with diabetes
Diabetic macular edema: Yes, direct
Cataracts: Higher risk in people with diabetes, but not exclusive to them
Dry eye: Not specific
Characteristic: Definitive diagnosis
Diabetic macular edema: Retinal OCT
Cataracts: Slit-lamp examination
Dry eye: Ocular surface tests
An important point: subjective visual acuity—what the patient perceives—does not always reflect the amount of fluid shown on OCT. Some cases involve considerable edema with relatively preserved vision, and vice versa. That is why imaging follow-up is essential.
Everyone diagnosed with diabetes should have regular eye assessments, whether or not they notice changes in their vision. Certain signs warrant an appointment without delay: sudden central blurred vision, distortion of straight lines, or a fixed shadow or spot in the visual field.
Signs that call for prompt assessment (not an emergency room visit, but do not put it off):
Sign that requires urgent care:
The American Academy of Ophthalmology guidelines recommend follow-up every 3 to 6 months for cases of noncentral DME, and more frequently when active central edema is being treated. (Diabetic Retinopathy Preferred Practice Pattern® - Ophthalmology) If you have diabetes and have never had a fundus exam, that is the first step.
OCT (optical coherence tomography) produces cross-sectional images of the retina with micron-level precision, without contact or radiation. In DME follow-up, its main role is to compare the condition of the retina between visits: whether the fluid has increased, decreased, or disappeared, and how the retina is responding to treatment.
OCT can quantify retinal thickness, monitor macular edema, identify vitreomacular traction, and detect other forms of macular disease. Major clinical trials of anti-VEGF therapy have favored OCT over stereoscopic photographs or clinical examination because it allows an objective, precise assessment of the amount and location of retinal thickening. (Diabetic Retinopathy Preferred Practice Pattern® - Ophthalmology)
All international clinical practice guidelines analyzed in a systematic review from 2025 recommend OCT to monitor DME during anti-VEGF treatment; 12 of 14 guidelines identify it as the tool for measuring response and adjusting the interval between doses. (Clinical practice guidelines for the treatment and management of diabetic macular oedema: a systematic review)
What OCT shows at each visit includes:
An OCT image is a tool for the specialist. Viewing it on a screen without the full clinical context—blood glucose history, number of previous injections, visual acuity measured that day—can lead to misinterpretations. Its value lies in the physician’s longitudinal assessment.
Treatment for DME depends on whether the edema involves the center of the macula, the degree of visual impairment, and each eye’s individual response. There is no single option that works for every case; the retina specialist selects a strategy based on the OCT findings and the patient’s systemic health.
Treatment options for DME include anti-VEGF therapy, macular laser photocoagulation, intravitreal steroid therapy, and observation. Laser is the preferred option for edema that does not involve the center; anti-VEGF is preferred for central edema with vision loss. (Diabetic Retinopathy: NICE 2024 Guideline Summary)
OCT monitoring is central to all of these options: it allows the physician to decide whether to continue the same regimen, space out visits if there is a favorable response, or intensify treatment if active fluid persists. For people whose disease has resolved after treatment, individualized monitoring is recommended during the first 12 months after therapy ends. (Diabetic Retinopathy: NICE 2024 Guideline Summary)
Metabolic control is an integral part of eye treatment. Glycated hemoglobin (HbA1c), blood pressure, and lipid levels directly affect treatment response and the likelihood of recurrence.
Eye care for people with diabetes does not begin at the clinic; it begins with daily habits. Sustained blood glucose control is the measure with the greatest demonstrated impact on reducing the risk and progression of DME. Each point of reduction in HbA1c represents a real long-term difference in the retina.
Reducing blood glucose and blood pressure levels may lower the risk of the disease progressing to proliferative diabetic retinopathy or diabetic macular edema. (Diabetic Retinopathy: NICE 2024 Guideline Summary)
Practical, realistic habits that make a difference:
The most common morphological patterns of DME identified by OCT are diffuse retinal thickening, cystoid macular edema, and serous retinal detachment; the latter is often associated with greater severity and poorer glycemic control. (Proportion, patterns and Factors Associated with Diabetic Macular Edema among Diabetes Type 2 Patients attending KCMC Hospital 2023-2024) Knowing the pattern of your edema helps your doctor anticipate your response to treatment.
If you have a family member with diabetes who has not yet had a fundus examination, accompanying them to their first consultation may be the most important preventive action you take this year.
At High Vision, the retina department coordinates with the cornea, dry eye, and cataract services because eye health in diabetes is rarely an isolated issue. A comprehensive assessment can detect overlapping conditions that might otherwise go unnoticed without a complete evaluation.
If you have diabetes and don’t remember when you last had a retina assessment, or if you’ve noticed any of the symptoms described in this article, schedule an appointment with the specialist to review your case and determine whether you need a follow-up OCT.
Your retina specialist will determine how often you need one based on the activity of the edema and the treatment you are receiving. During the active phase of anti-VEGF treatment, OCT is usually performed every 4 to 6 weeks. Once the edema stabilizes, the intervals are extended.
This is not recommended. OCT requires comparative interpretation with previous studies, correlation with visual acuity measured that day, and consideration of the full clinical context. An isolated image viewed outside that context may lead to incorrect conclusions about your actual condition.
It does not replace it; it complements it. OCT is the preferred test for routine monitoring because it is noninvasive and highly accurate for measuring fluid. Angiography is indicated when the specialist needs to evaluate retinal circulation or detect areas of leakage that OCT does not directly show.
That decision is solely up to your retina specialist. Improvement in retinal thickness is a positive sign, but stopping treatment without an assessment may cause the edema to recur. Your doctor will evaluate the response pattern before changing the treatment plan.
If left untreated, DME can cause progressive and irreversible structural damage to the macula. With timely detection and appropriate follow-up, most patients can preserve useful visual function. The timing of diagnosis and treatment initiation is a key factor.
Yes, sustained blood glucose control supports the response to treatment and may reduce the recurrence of edema. It does not replace ophthalmic treatment, but it is a factor your retina specialist considers when evaluating how your condition is progressing.